---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-041362"
form_type: "8-K"
ticker: "ANEB"
cik: "0001815974"
company_name: "Anebulo Pharmaceuticals, Inc."
filed_at: "2024-10-17T23:59:59+00:00"
generated_at: "2026-05-30T13:25:07.380648+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Anebulo updates corporate presentation; no specific changes disclosed in filing extract

## Summary
- Company furnished an updated Corporate Presentation as Exhibit 99.1 under Item 7.01.
- Presentation content is not included in the provided text; details of updates are unknown.
- No forward-looking statements or material financial data were available for review.
- Investors should request the full presentation from the company for substantive changes.

## SEC filing metadata
- accession: 0001493152-24-041362
- form_type: 8-K
- ticker: ANEB
- cik: 0001815974
- company_name: Anebulo Pharmaceuticals, Inc.
- filed_at: 2024-10-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815974/000149315224041362/0001493152-24-041362-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815974/000149315224041362/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-041362
- JSON: https://secwatch.observer/filing/0001493152-24-041362.json
- Plain text: https://secwatch.observer/filing/0001493152-24-041362.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.